1 Start 2 Complete

2022-23 Annual Updates in Management of Hematologic Malignancies - ASH 2022 Update

April 6, 2023

*
Rating (1=low, 5=high)
12345
Provide updates in the management of acute leukemia, myloproliferative neoplasms, AML, MDS, lymphoma, and myeloma
Increased knowledge of the changing definitions of acute myeloid leukemia (AML) and myelodysplasia (MDS)
Discuss the management of immunotherapies in myeloma and lymphoma
Define the application of novel therapies for patients with blood cancers to improve their survival
*
1 strongly disagree 2 disagree 3 unsure 4 agree 5 strongly agree
12345
My knowledge increased.
My ability to provide appropriate care to my patients improved.
I feel a decreased sense of professional isolation.
Relevance to your practice.
*
*
*
*
*
*